Details of the Drug Reposition

General Information of This Drug (ID: DMXF6TP)

Drug Name
Selenium sulfide   DMXF6TP
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pityriasis simplex DIS1K9V6 N.A. Approved [1]
Tinea versicolor DIS5VG35 1F2D.0 Approved [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Seborrhoeic dermatitis DISNWVJU EA81 Discontinued in Phase 3 [2]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Erythema DISUL5AN ME64.0 Investigative [3]
------------------------------------------------------------------------------------

References

1 Selenium sulfide FDA Label
2 Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015